Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A systematic review of the non-surgical treatment of Perthes' disease.

Galloway AM. et al, (2020), Bone Jt Open, 1, 720 - 730

A successful strategy for recruiting participants not in a care pathway to a CTIMP on time and to target

Francis A. et al, (2019), TRIALS, 20

Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.

Nanchahal J. et al, (2018), EBioMedicine, 33, 282 - 288

What do we know about managing Dupuytren's disease cost-effectively?

Dritsaki M. et al, (2018), BMC Musculoskelet Disord, 19

Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren’s disease, with an embedded dose response study.

Nanchahal J. et al, (2017)

Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study.

Nanchahal J. et al, (2017), Wellcome Open Res, 2

Tonometry as an outcome measure for early Dupuytren's disease

BALL C. et al, (2016), Dupuytren Disease and Related Diseases - The Cutting Edge

Variation in range of movement reporting in Dupuytren disease

BALL C. and Pratt A., (2016), Dupuytren Disease and Related Diseases - The Cutting Edge

Systematic review of non-surgical treatments for early dupuytren’s disease

Ball CE. et al, (2016), Biomedcentral Musculoskeletal Disorders

Systematic review of non-surgical treatments for early dupuytren's disease.

Ball C. et al, (2016), BMC Musculoskelet Disord, 17

ISBN 978-1-905944-54-5

College of Occupational Therapists None., (2016)

What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Pratt AL. and Ball C., (2016), BMC Musculoskelet Disord, 17

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.

Ball CE. et al, (2015), British Association of Hand Therapists Annual Conference

Surgery for Dupuytren's contracture of the fingers.

Rodrigues JN. et al, (2015), Cochrane Database Syst Rev

Investigation and treatment of carpal tunnel syndrome in one visit - results of an accelerated clinical pathway.

Ball CE. et al, (2015), Royal College of General PractitionAnnual Conference

Tonometry as an outcome measure for the treatment of Dupuytren’s disease.

Ball CE. et al, (2015)

Dupuytren’s disease – the role of hand therapy

Ball CE. and Pratt AL., (2015), Living Textbook of Hand Surgery

Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Ball C. et al, (2013), BMC Musculoskelet Disord, 14

ANTI-TNF THERAPY IMPROVES HAND FUNCTION IN RHEUMATOID ARTHRITIS WITHIN 3 MONTHS

Hull D. et al, (2012), RHEUMATOLOGY, 51, 136 - 136

HAND AND UPPER LIMB FUNCTION ASSESSMENT IN RHEUMATOID ARTHRITIS

Ball C., (2012), RHEUMATOLOGY, 51, 16 - 16

Load More

Include forthcoming?